Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEAP THERAPEUTICS, INC. | Chief Operating Officer | Common Stock | 678K | $1.91M | $2.82 | Nov 13, 2024 | Indirect |
LEAP THERAPEUTICS, INC. | Chief Operating Officer | Common Stock | 5.09K | $14.3K | $2.82 | Nov 13, 2024 | Direct |
LEAP THERAPEUTICS, INC. | Chief Operating Officer | Restricted Stock Units | 0 | $0 | $2.85 | Jan 26, 2024 | Direct |
LEAP THERAPEUTICS, INC. | Chief Operating Officer | Employee Stock Option (Right to Buy) | 85K | Oct 2, 2024 | Direct | ||
LEAP THERAPEUTICS, INC. | Chief Operating Officer | Employee Stock Option (Right to Buy) | 85K | Jan 29, 2024 | Direct | ||
Cardiovascular Systems Inc | Director | Common Stock | 0 | $20.00 | Apr 27, 2023 | By Lawlor Family Trust | |
Cardiovascular Systems Inc | Director | Common Stock | 0 | $20.00 | Apr 27, 2023 | Direct | |
Cardiovascular Systems Inc | Director | Restricted Stock Units | 0 | Apr 27, 2023 | Direct | ||
CATALYST BIOSCIENCES, INC. | Director | Series Y Preferred Stock | 0 | Aug 31, 2023 | By The Lawlor Family Trust UAD 4-17-00 | ||
CATALYST BIOSCIENCES, INC. | Director | Series Y Preferred Stock | 0 | Aug 31, 2023 | Direct | ||
LEAP THERAPEUTICS, INC. | Chief Operating Officer | Warrant (Right to Buy) | 0 | Nov 13, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LPTX | LEAP THERAPEUTICS, INC. | Nov 13, 2024 | 2 | $6.02K | 4 | Nov 15, 2024 | Chief Operating Officer |
LPTX | LEAP THERAPEUTICS, INC. | Oct 2, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Chief Operating Officer |
LPTX | LEAP THERAPEUTICS, INC. | Jan 29, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Chief Operating Officer |
LPTX | LEAP THERAPEUTICS, INC. | Jan 26, 2024 | 2 | $0 | 4 | Jan 30, 2024 | Chief Operating Officer |
CBIO | CATALYST BIOSCIENCES, INC. | Aug 31, 2023 | 2 | $0 | 4 | Sep 1, 2023 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Aug 23, 2023 | 1 | $0 | 4 | Aug 25, 2023 | Chief Operating Officer |
CSII | Cardiovascular Systems Inc | Apr 27, 2023 | 3 | -$607K | 4 | Apr 27, 2023 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Operating Officer |
LPTX | LEAP THERAPEUTICS, INC. | Sep 1, 2022 | 1 | $0 | 4 | Sep 2, 2022 | Chief Operating Officer |
CSII | Cardiovascular Systems Inc | Aug 5, 2022 | 1 | $0 | 4 | Aug 9, 2022 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Operating Officer, 10%+ Owner |
CSII | Cardiovascular Systems Inc | Nov 15, 2021 | 1 | $0 | 4 | Nov 17, 2021 | Director |
CBIO | CATALYST BIOSCIENCES, INC. | Oct 1, 2021 | 1 | $0 | 4 | Oct 5, 2021 | Director |
CSII | Cardiovascular Systems Inc | Aug 9, 2021 | 2 | $0 | 4 | Aug 11, 2021 | Director |
CBIO | CATALYST BIOSCIENCES, INC. | Jun 9, 2021 | 2 | $0 | 4 | Jul 2, 2021 | Director |
LPTX | LEAP THERAPEUTICS, INC. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Chief Operating Officer, 10%+ Owner |